{"schema_version":"secwatch.filing_event.v1","accession":"0000320017-22-000094","form_type":"8-K","ticker":"LSTA","cik":"0000320017","company_name":"LISATA THERAPEUTICS, INC.","filed_at":"2022-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.773198+00:00","generated_at":"2026-06-23T06:50:22.940330+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lisata regains Nasdaq minimum bid price compliance; delisting risk removed","bullets":["Received Nasdaq deficiency letter on Feb 18, 2022 for bid price below $1.00.","Granted initial 180-day period ending Aug 17, 2022, then second period to Feb 13, 2023.","On Sept 29, 2022, notified compliance regained after 10 consecutive days at $1.00+.","Nasdaq confirmed the matter is now closed.","Stock ticker LSTA remains listed on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0000320017-22-000094","json":"https://secwatch.observer/filing/0000320017-22-000094.json","markdown":"https://secwatch.observer/filing/0000320017-22-000094.md","text":"https://secwatch.observer/filing/0000320017-22-000094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/320017/000032001722000094/0000320017-22-000094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/320017/000032001722000094/clbs-20220929.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:50:22.940330+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}